GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » YoY EBITDA Growth

Lobe Sciences (Lobe Sciences) YoY EBITDA Growth : 76.19% (As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Lobe Sciences's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was 76.19%.

Lobe Sciences's EBITDA per Share for the three months ended in Feb. 2024 was $-0.01.


Lobe Sciences YoY EBITDA Growth Historical Data

The historical data trend for Lobe Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences YoY EBITDA Growth Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.68 -352.78 4.91 -61.29 87.60

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.50 84.62 100.00 97.33 76.19

Lobe Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Lobe Sciences's YoY EBITDA Growth for the fiscal year that ended in Aug. 2023 is calculated as:

YoY EBITDA Growth (A: Aug. 2023 )
=(EBITDA per Share (A: Aug. 2023 )-EBITDA per Share (A: Aug. 2022 ))/ | EBITDA per Share (A: Aug. 2022 ) |
=(-0.031--0.25)/ | -0.25 |
=87.60 %

Lobe Sciences's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY EBITDA Growth (Q: Feb. 2024 )
=(EBITDA per Share (Q: Feb. 2024 )-EBITDA per Share (Q: Nov. 2022 )) / | EBITDA per Share (Q: Nov. 2022 )) |
=(-0.005--0.021)/ | -0.021 |
=76.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (Lobe Sciences) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.